Oligonucleotide CDMOs
40 published
40 published CDMOs match Oligonucleotide.
Locations in this set include United States, China, United Kingdom, Switzerland, Canada, and India.
Capabilities that show up most often in this set: CMC Analytical Development, Oligonucleotide Manufacturing, Process Development, Quality Control Testing, and Technology Transfer.
Matching companies
GBI BiomanufacturingFull-service biologics CDMO offering integrated development and manufacturing services including cell banking, upstream/downstream processing, bioconjugation, aseptic fill-finish, and regulatory support for complex biopharmaceuticals.
Galenvs SciencesGalenvs makes modified, specialty oligonucleotides for drug and gene-therapy programs, from proof of concept to pilot scale, under an ISO 9001:2015 certified quality system.
Global Biotech LaboratoriesGlobal Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents.
HitGen Inc.HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
Hongene Biotech CorporationHongene is a vertically-integrated CDMO offering end-to-end oligonucleotide and mRNA manufacturing from raw materials to GMP drug product, with nearly 30 years of RNA-focused expertise and tonne-scale production capacity.
LGC Biosearch TechnologiesGMP-compliant manufacturer of custom oligos, qPCR probes, and diagnostic kits for infectious diseases, oncology, and prenatal testing; ISO 13485-certified for clinical and diagnostic markets.
Maravai LifeSciencesLeading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.
PharmaBlockLeading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
PhosphorexPhosphorex specializes in advanced drug delivery system design and optimization, offering formulation development, process design, analytical expertise, and tech transfer services for gene therapies, mRNA, and other complex therapeutics.
PortonPorton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
Sapala OrganicsCustom synthesis of nucleic acid building blocks, modified phosphoramidites and oligonucleotide delivery compounds, plus FTE-based CRO and fee-for-service CDMO engagements. Orthogonal analytical services serve clients from early R&D through pharma innovators.
Singota SolutionsBloomington-based CDMO specializing in aseptic filling of small-volume parenterals (vials, syringes, cartridges), formulation development, QC testing, and supply chain management with GMP-compliant operations.
Sinopep-Allsino Biopharmaceutical Co., Ltd.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Sophia CDMOEuropean CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.
Stevanato GroupLeading global provider of integrated drug containment, drug delivery, and diagnostic solutions with 75+ years' experience in glass primary packaging, contract manufacturing, and analytical services across development, clinical, and commercial stages.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TriLink BioTechnologiesTriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
VeranovaGlobal CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.
atdbioATDBio provides custom oligonucleotide synthesis, purification, and analysis services for research, diagnostics, and therapeutic applications.
Markdown mirror: /modalities/oligonucleotide.md